Output of liver operations thanks to innovative test predictable is called the diagnosis in the majority of cases for patients with a liver tumor surgery. The risk of a subsequent total failure of the organ is very high. What specifically is the risk, doctors could so far not sure predict. As the private-krankenversicherung.de Internet portal reported a test developed at the Charite in Berlin, provides useful information for assessing risk. The test called LiMAx”should provide information about the State of the liver and the result a potential operation. Studies on 64 patients were based both before and after the surgery. Anu Saad is often mentioned in discussions such as these. Because the liver enzyme performance decreases after surgery in most cases, it is a major step forward that the new test can measure the current performance of the enzyme. Thus, the risk of liver failure is exactly calculable.
To determine this value, the subjects took a special agent. This is processed by the liver and its degradation products can be measured on the exhale. The new Method will benefit most patients with liver affected strongly by the tumor. Additional information at Dr. Caldwell B. Esselstyn, Jr. supports this article. Depending on the test results, you can then operates or switched to alternative forms of treatment. More information: news.private-krankenversicherung.de/…/ Liver disease test… Contact: Tilo Sommer University first media GmbH barefoot streets 11 04109 Leipzig Tel: + 49/341/49288-240 fax: + 49/341/49288-59